We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
+0.61%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$14.7B
AUM Growth
+$1.55B
Cap. Flow
-$42.4M
Cap. Flow %
-0.29%
Top 10 Hldgs %
33.58%
Holding
2,110
New
660
Increased
423
Reduced
368
Closed
648

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$231M
2
COP icon
ConocoPhillips
COP
+$114M
3
AAPL icon
Apple
AAPL
+$80.8M
4
BDX icon
Becton Dickinson
BDX
+$68.3M
5
SHW icon
Sherwin-Williams
SHW
+$62.8M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$351M
2
META icon
Meta Platforms (Facebook)
META
+$242M
3
GPN icon
Global Payments
GPN
+$202M
4
FCX icon
Freeport-McMoran
FCX
+$70.4M
5
PPL
PPL Corp
PPL
+$61.6M

Sector Composition

Rank Sector Weight
1 Healthcare 10.2%
2 Technology 10.13%
3 Utilities 6.69%
4 Consumer Discretionary 6.52%
5 Industrials 5.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AGIO icon
1476
Agios Pharmaceuticals
AGIO
$1.98B
– –
-101,612
Closed -$2.97M
AGM icon
1477
Federal Agricultural Mortgage
AGM
$2.4B
– –
-9,393
Closed -$1.85M
AHCO icon
1478
AdaptHealth
AHCO
$751M
– –
-58,721
Closed -$676K
AIG icon
1479
PUT
American International
AIG
$39.8B
– –
-200,000
Closed -$15.6M
AIP icon
1480
Arteris
AIP
$1.17B
– –
-20,608
Closed -$151K
AJG icon
1481
Arthur J. Gallagher & Co
AJG
$67.6B
– –
-2,680
Closed -$670K
AKAM icon
1482
Akamai
AKAM
$15.9B
– –
-12,135
Closed -$1.32M
AKBA icon
1483
Akebia Therapeutics
AKBA
$251M
– –
-137,742
Closed -$252K
ALGM icon
1484
Allegro MicroSystems
ALGM
$6.93B
– –
-285,046
Closed -$7.68M
ALGN icon
1485
Align Technology
ALGN
$11.5B
– –
-14,906
Closed -$4.89M
ALGT icon
1486
Allegiant Air
ALGT
$2.24B
– –
-40,211
Closed -$3.02M
ALNY icon
1487
Alnylam Pharmaceuticals
ALNY
$31.6B
– –
-18,658
Closed -$2.79M
ALNT icon
1488
Allient
ALNT
$1.63B
– –
-7,861
Closed -$280K
ALTG icon
1489
Alta Equipment Group
ALTG
$212M
– –
-40,150
Closed -$520K
ALTO icon
1490
Alto Ingredients
ALTO
$340M
– –
-19,470
Closed -$42K
ALXO icon
1491
ALX Oncology
ALXO
$282M
– –
-23,366
Closed -$261K
AM icon
1492
Antero Midstream
AM
$10.5B
– –
-292,500
Closed -$4.11M
AMAT icon
1493
Applied Materials
AMAT
$391B
– –
-25,003
Closed -$5.16M
OSG
1494
Octave Specialty Group
OSG
$205M
– –
-37,388
Closed -$584K
AMCX icon
1495
AMC Global Media
AMCX
$511M
– –
-11,609
Closed -$141K
AMP icon
1496
Ameriprise Financial
AMP
$49.1B
– –
-21,934
Closed -$9.62M
GOLD
1497
Gold.com Inc
GOLD
$1.34B
– –
-21,756
Closed -$668K
AMSC icon
1498
American Superconductor
AMSC
$1.45B
– –
-59,499
Closed -$804K
AMZN icon
1499
CALL
Amazon
AMZN
$2.79T
– –
-244,700
Closed -$44.1M
ANIK icon
1500
Anika Therapeutics
ANIK
$291M
– –
-15,562
Closed -$395K
58 59
60
61 62

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q2 2024 Portfolio in Review

As of Q2 2024, Michael Gelband held 2,110 positions worth $14.7B, up 12% from $13.1B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Michael Gelband's Q2 2024 filing shows 660 new, 423 increased, 368 reduced and 648 closed positions. Its largest new stake was Coca-Cola: 936,563 shares worth $59.6M. The largest sale was NVIDIA, an estimated $351M.

By sector, the portfolio is most concentrated in Healthcare at 10% of assets, up from 6.9% a quarter earlier, followed by Technology and Utilities.

  • Michael Gelband's largest Q2 2024 buy was Coca-Cola: 936,563 shares worth $59.6M.
  • Michael Gelband added most to Amazon in Q2 2024, an estimated $231M increase.
  • Michael Gelband's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $351M.
  • Michael Gelband fully exited Global Payments in Q2 2024, selling an estimated $202M.
  • Michael Gelband's ten largest holdings make up 34% of its $14.7B portfolio in Q2 2024.
  • Michael Gelband opened 660 new positions and closed 648 in Q2 2024.
  • Michael Gelband's portfolio value rose 12% quarter-over-quarter to $14.7B.

Based on ExodusPoint Capital Management's 13F filing for Q2 2024, filed 13 Aug 2024.